| 今开：51.65 | 昨收：51.65 |
| 最高：51.835 | 最低：51.14 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.1616981863E10 |
JZee03-29 13:32
$因塞特医疗(INCY)$ 这个ruxolitinib软膏外用治疗皮肤病，看目前的走量还是挺有前途的，原来还真不知道jak抑制剂可以治疗白癜风。jak抑制剂外用看起来安全性还不错。专利目前到2031。jakafi本身专利到2028.查看全文
因塞特医疗(INCY)02-17 05:15
$因塞特医疗(INCY)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000879169-24-000062 Act: 34 Size: 360 KB 网页链接查看全文
因塞特医疗(INCY)02-17 01:55
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000056 Size: 5 KB 网页链接查看全文
因塞特医疗(INCY)02-14 05:05
$因塞特医疗(INCY)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000879169-24-000045 Act: 34 Size: 11 MB 网页链接查看全文
因塞特医疗(INCY)02-14 06:15
$因塞特医疗(INCY)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-020600 Act: 33 Size: 452 KB 网页链接查看全文
因塞特医疗(INCY)02-14 06:15
$因塞特医疗(INCY)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-021175 Act: 34 Size: 13 KB 网页链接查看全文
因塞特医疗(INCY)02-15 01:35
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000047 Size: 5 KB 网页链接查看全文
因塞特医疗(INCY)02-17 01:55
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000057 Size: 5 KB 网页链接查看全文
因塞特医疗(INCY)02-17 01:55
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000060 Size: 7 KB 网页链接查看全文
因塞特医疗(INCY)04-03 00:15
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000069 Size: 5 KB 网页链接查看全文
智通财经APP获悉，当地时间6月13日，美国FDA宣布批准礼来(LLY.US)和因塞特(INCY.US)联合开发的口服JAK抑制剂巴瑞替尼(英文商品名Olumiant)上市，用于治疗严重斑秃成人患者。值得一提的是，这是美国FDA批准用于治疗斑秃的首款系统性疗法... 网页链接
智通财经APP获悉，美国FDA于当地时间7月29日扩大了礼来(LLY.US)与因塞特医疗(INCY.US)的baricitinib药物(商用名Olumiant)的紧急适用授权(EUA)。根据修订后的EUA，治疗确诊新冠的住院患者时，baricitinib不需与吉利德科学(GILD.US)的Vekl... 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000069 Size: 5 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000070 Size: 5 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-039366 Size: 24 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000066 Size: 7 KB 网页链接
$因塞特医疗(INCY)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000879169-24-000065 Size: 275 KB 网页链接
$因塞特医疗(INCY)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-038500 Size: 35 KB 网页链接
$因塞特医疗(INCY)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000879169-24-000062 Act: 34 Size: 360 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000059 Size: 5 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000058 Size: 5 KB 网页链接
$因塞特医疗(INCY)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000879169-24-000057 Size: 5 KB 网页链接